165 related articles for article (PubMed ID: 24223206)
1. A novel chordoma xenograft allows in vivo drug testing and reveals the importance of NF-κB signaling in chordoma biology.
Trucco MM; Awad O; Wilky BA; Goldstein SD; Huang R; Walker RL; Shah P; Katuri V; Gul N; Zhu YJ; McCarthy EF; Paz-Priel I; Meltzer PS; Austin CP; Xia M; Loeb DM
PLoS One; 2013; 8(11):e79950. PubMed ID: 24223206
[TBL] [Abstract][Full Text] [Related]
2. Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.
Karikari IO; Gilchrist CL; Jing L; Alcorta DA; Chen J; Richardson WJ; Gabr MA; Bell RD; Kelley MJ; Bagley CA; Setton LA
J Neurosurg Spine; 2014 Sep; 21(3):386-93. PubMed ID: 24905390
[TBL] [Abstract][Full Text] [Related]
3. Development of transplantable human chordoma xenograft for preclinical assessment of novel therapeutic strategies.
Bozzi F; Manenti G; Conca E; Stacchiotti S; Messina A; Dagrada G; Gronchi A; Panizza P; Pierotti MA; Tamborini E; Pilotti S
Neuro Oncol; 2014 Jan; 16(1):72-80. PubMed ID: 24366975
[TBL] [Abstract][Full Text] [Related]
4. Establishment and characterization of a primary human chordoma xenograft model.
Siu IM; Salmasi V; Orr BA; Zhao Q; Binder ZA; Tran C; Ishii M; Riggins GJ; Hann CL; Gallia GL
J Neurosurg; 2012 Apr; 116(4):801-9. PubMed ID: 22283186
[TBL] [Abstract][Full Text] [Related]
5. Genetic landscape and ligand-dependent activation of sonic hedgehog-Gli1 signaling in chordomas: a novel therapeutic target.
Yang C; Yong L; Liang C; Li Y; Ma Y; Wei F; Jiang L; Zhou H; He G; Pan X; Hai B; Wu J; Xu Y; Liu Z; Liu X
Oncogene; 2020 Jun; 39(24):4711-4727. PubMed ID: 32404987
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of skull base chordoma tailored on responsiveness of patient-derived tumor cells to rapamycin.
Ricci-Vitiani L; Runci D; D'Alessandris QG; Cenci T; Martini M; Bianchi F; Maira G; Stancato L; De Maria R; Larocca LM; Pallini R
Neoplasia; 2013 Jul; 15(7):773-82. PubMed ID: 23814489
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a Clival Chordoma Xenograft Model Reveals Tumor Genomic Instability.
Diaz RJ; Luck A; Bondoc A; Golbourn B; Picard D; Remke M; Loukides J; Sabha N; Smith C; Cusimano MD; Rutka JT
Am J Pathol; 2018 Dec; 188(12):2902-2911. PubMed ID: 30248342
[TBL] [Abstract][Full Text] [Related]
8. Erlotinib inhibits growth of a patient-derived chordoma xenograft.
Siu IM; Ruzevick J; Zhao Q; Connis N; Jiao Y; Bettegowda C; Xia X; Burger PC; Hann CL; Gallia GL
PLoS One; 2013; 8(11):e78895. PubMed ID: 24260133
[TBL] [Abstract][Full Text] [Related]
9. EGFR inhibitors identified as a potential treatment for chordoma in a focused compound screen.
Scheipl S; Barnard M; Cottone L; Jorgensen M; Drewry DH; Zuercher WJ; Turlais F; Ye H; Leite AP; Smith JA; Leithner A; Möller P; Brüderlein S; Guppy N; Amary F; Tirabosco R; Strauss SJ; Pillay N; Flanagan AM
J Pathol; 2016 Jul; 239(3):320-34. PubMed ID: 27102572
[TBL] [Abstract][Full Text] [Related]
10. Afatinib Is a New Therapeutic Approach in Chordoma with a Unique Ability to Target EGFR and Brachyury.
Magnaghi P; Salom B; Cozzi L; Amboldi N; Ballinari D; Tamborini E; Gasparri F; Montagnoli A; Raddrizzani L; Somaschini A; Bosotti R; Orrenius C; Bozzi F; Pilotti S; Galvani A; Sommer J; Stacchiotti S; Isacchi A
Mol Cancer Ther; 2018 Mar; 17(3):603-613. PubMed ID: 29237806
[TBL] [Abstract][Full Text] [Related]
11. Identification of repurposed small molecule drugs for chordoma therapy.
Xia M; Huang R; Sakamuru S; Alcorta D; Cho MH; Lee DH; Park DM; Kelley MJ; Sommer J; Austin CP
Cancer Biol Ther; 2013 Jul; 14(7):638-47. PubMed ID: 23792643
[TBL] [Abstract][Full Text] [Related]
12. Generation of a patient-derived chordoma xenograft and characterization of the phosphoproteome in a recurrent chordoma.
Davies JM; Robinson AE; Cowdrey C; Mummaneni PV; Ducker GS; Shokat KM; Bollen A; Hann B; Phillips JJ
J Neurosurg; 2014 Feb; 120(2):331-6. PubMed ID: 24286145
[TBL] [Abstract][Full Text] [Related]
13. Personalized chordoma organoids for drug discovery studies.
Al Shihabi A; Davarifar A; Nguyen HTL; Tavanaie N; Nelson SD; Yanagawa J; Federman N; Bernthal N; Hornicek F; Soragni A
Sci Adv; 2022 Feb; 8(7):eabl3674. PubMed ID: 35171675
[TBL] [Abstract][Full Text] [Related]
14. Role of the transcription factor T (brachyury) in the pathogenesis of sporadic chordoma: a genetic and functional-based study.
Presneau N; Shalaby A; Ye H; Pillay N; Halai D; Idowu B; Tirabosco R; Whitwell D; Jacques TS; Kindblom LG; Brüderlein S; Möller P; Leithner A; Liegl B; Amary FM; Athanasou NN; Hogendoorn PC; Mertens F; Szuhai K; Flanagan AM
J Pathol; 2011 Feb; 223(3):327-35. PubMed ID: 21171078
[TBL] [Abstract][Full Text] [Related]
15. AZD8055 enhances in vivo efficacy of afatinib in chordomas.
Zhao T; Siu IM; Williamson T; Zhang H; Ji C; Burger PC; Connis N; Ruzevick J; Xia M; Cottone L; Flanagan AM; Hann CL; Gallia GL
J Pathol; 2021 Sep; 255(1):72-83. PubMed ID: 34124783
[TBL] [Abstract][Full Text] [Related]
16. Establishment and characterization of a novel chordoma cell line: CH22.
Liu X; Nielsen GP; Rosenberg AE; Waterman PR; Yang W; Choy E; Sassi S; Yang S; Harmon DC; Yang C; Schwab JH; Kobayashi E; Mankin HJ; Xavier R; Weissleder R; Duan Z; Hornicek FJ
J Orthop Res; 2012 Oct; 30(10):1666-73. PubMed ID: 22504929
[TBL] [Abstract][Full Text] [Related]
17. Higher cMET dependence of sacral compared to clival chordoma cells: contributing to a better understanding of cMET in chordoma.
Lohberger B; Scheipl S; Heitzer E; Quehenberger F; de Jong D; Szuhai K; Liegl-Atzwanger B; Rinner B
Sci Rep; 2021 Jun; 11(1):12466. PubMed ID: 34127734
[TBL] [Abstract][Full Text] [Related]
18. The role of epidermal growth factor receptor in chordoma pathogenesis: a potential therapeutic target.
Shalaby A; Presneau N; Ye H; Halai D; Berisha F; Idowu B; Leithner A; Liegl B; Briggs TR; Bacsi K; Kindblom LG; Athanasou N; Amary MF; Hogendoorn PC; Tirabosco R; Flanagan AM
J Pathol; 2011 Feb; 223(3):336-46. PubMed ID: 21171079
[TBL] [Abstract][Full Text] [Related]
19. Establishment and genomic characterization of the new chordoma cell line Chor-IN-1.
Bosotti R; Magnaghi P; Di Bella S; Cozzi L; Cusi C; Bozzi F; Beltrami N; Carapezza G; Ballinari D; Amboldi N; Lupi R; Somaschini A; Raddrizzani L; Salom B; Galvani A; Stacchiotti S; Tamborini E; Isacchi A
Sci Rep; 2017 Aug; 7(1):9226. PubMed ID: 28835717
[TBL] [Abstract][Full Text] [Related]
20. Drug combination screening as a translational approach toward an improved drug therapy for chordoma.
Scheipl S; Barnard M; Lohberger B; Zettl R; Brcic I; Liegl-Atzwanger B; Rinner B; Meindl C; Fröhlich E
Cell Oncol (Dordr); 2021 Dec; 44(6):1231-1242. PubMed ID: 34550531
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
